(WASHINGTON) #Coronavirus Remdesivir Drug Report: Trump administration says it has locked down nearly the entire supply of one of the only available anti-#COVID19 drugs from the manufacturer for the next several months: That raises questions about access to one of the few treatments for much of the rest of the world and rumours about charges in the U.S. of $3,000 according to CNBC even though manufacturer Cipla says they will charge $66.00 #AceHealthDesk